Medical anthropologist Carole H. Browner, Ph.D., will speak on “Gender, Health and Reproduction: Transnational Perspectives” at 7:30 p.m. Thursday, Feb. 11, in the Women’s Building Formal Lounge. The lecture is part of the new Initiative on Gender, Sexuality, and Health.
Researchers at Washington University School of Medicine in St. Louis have shown once again that “ready, fire, aim,” nonsensical though it may sound, can be an essential approach to research.
The Danforth Campus has more than 12,000 students, 4,500-plus faculty and staff and 5,168 parking spaces. Teams of Olin Business School students have been crunching the numbers since December in hopes of solving the campus parking challenge and winning the grand prize of $5,000 in the first Olin Sustainability Case Competition. Four teams compete in the final round Friday, Feb. 12.
Pulitzer Prize-winning author and historian Edward J. Larson will present, “From Dayton to Dover: A Brief History of the Evolution Teaching Controversy in the U.S.” at 4 p.m. Wednesday, Feb. 10, in Louderman Hall, Room 458. The Assembly Series program is this year’s Thomas S. Hall Lecture.
Serendipity is a word that Kathleen K. Bucholz, Ph.D., uses a lot as she describes her career path. She didn’t really start out to be a psychiatric epidemiologist or to study how genes and environment intersect to contribute to problems with alcohol. In fact, for much of college, science was an afterthought.
Chancellor Mark S. Wrighton addresses the WUSTL community, giving a summary of results of the plan to assure the university’s financial strength and continue its mission of education, research, patient care, and service.
Thomas J. Hannan, DVM, research instructor in pathology and immunology, has received a three-year, $355,942 grant from the National Institute of Allergy and Infectious Diseases for research titled “Mucosal Immune Checkpoints in Chronic Bacterial Cystitis.” … Rakesh Nagarajan, M.D., Ph.D., associate professor of pathology and immunology, has received a three-year, $106,221 subaward through the University […]
The first head-to-head comparison of therapeutic monoclonal antibodies produced from plants versus the same antibodies produced from mammalian cells has shown that plant-produced antibodies can fight infection equally well. Scientists conducted the comparison as a test of the potential for treating disease in developing nations with the significantly less expensive plant-based production technique.
